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Available online ▪ ▪ ▪AbstractCryptococcus neoformans is the most common opportunistic CNS fungal pathogen in HIV-positive patients. About 7%e8% of the HIV-
positive patients will have cryptococcal meningoencephalitis. Imaging plays an important role in the evaluation of cryptococcal infection of
the brain. Abnormal findings correlated with higher risk of death. The paper will review the pathogenesis, pathology, imaging characterization
and complication combined with cryptococcal meningoencephalitis.
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Cryptococcus neoformans was first described by Verse' and
then confirmed by Stoddard and Cutler 2 years later [1]. It is
reported that the pathogen of cryptococcus is most common
seen in nests and droppings of pigeon. Two types of Cryp-
tococcus were grouped including C. neoformans and Cryp-
tococcus gattii [1]. Cryptococcus infection caused by C.
neoformans accounts for 80% and 20% by C. gattii. Infection
from C. neoformans is most common seen in CNS but C.
gattii infection is much more seen in lung [2].
Although cryptococcal infection is worldwide distribution,
it is more commonly seen in the immuno-compromised pa-
tients. C. neoformans is the most common opportunistic CNSAbbreviations: C. neoformans, Cryptococcus neoformans; CNS, central
nervous system; HIV, human immunodeficiency virus; AIDS, acquired im-
munodeficiency syndrome; ICH, Intracranial hypertension; VRS, Virchow
Robin spaces; DWI, diffusion weighted imaging; ADC, apparent diffusion
coefficient; FLAIR, fluid attenuate inversion; IRS, Immune reconstitution
syndrome.
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of the HIV-positive patients will have cryptococcal menin-
goencephalitis [4,5]. The incidence of cryptococcal infection
in patients with AIDS varies from 2% to 10% in U.S and
western Europe and up to 15% in Africa and Asia [6e8]. HIV
infection is the leading factors along with estimated over
700,000 cases deaths annually and most common in sub-
Saharan Africa [9]. Others factors included, long time use
of corticosteroids, advanced malignancy, organ trans-
plantation and so on [10,11]. The infection of cryptococcus
can also occur in the immuno-competent patients, especially
in the C. gattii infection [12]. With the development of
immunology, new risk factors in apparently normal crypto-
coccal patients may be uncovered [13].2. Pathogenesis of cryptococcal meningoencephalitis
It is important to understand the pathogenesis of the cryp-
tococcus with the increasing rate of AIDS. The cryptococcal
infection first initiated in the lung through inhalation of yeast
cells. In a host with normal immune, inhaled cryptococci can
be eliminated effectively. But in the immuno-compromised
patients, the cryptococcal cells can proliferate, disseminate
to the central nervous system, heamatogenously crossing thecoccal meningoencephalitis, Radiology of Infectious Diseases (2016), http://
. Production and hosting by Elsevier B.V. This is an open access article under
Fig. 1. Dilated Virchow-Robin spaces. Multiple cystic lesions were shown at
the bilateral basal ganglia. Hyperintensity were shown on T2WI.
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There are no effective anti-cryptococcal factors in the cerebral
spinal fluid (CSF) and the fungal the polysaccharide capsule
can also avoid it from host inflammatory response [15].
Parenchymal or sub ependymal invasion of cryptococci are
mostly coming through perivascular and subarachnoid space
[16e19]. The lesions of basal ganglia are major heamatoge-
neously spread. Although any organ can be infected by
cryptococci, CNS involvement is much more common and is
the most common cause for patients' death. Another common
situation is that the pathogen is dormant, when the patients'
immunity decreased, the cells can be activated and leading to
spread [1].
3. Pathology of cryptococcal meningoencephalitis
Three types of pathology could be seen in the cryptococcal
meningoencephalitis [19]. First, slight inflammatory reaction
combined with lymphocytes and few plasmocytes infiltration
in 70% AIDS patients. Second, large amount of gelatinous
pseudocysts with lots of C. neoformans in the VRS and
adjacent basal brain caused through disseminating from the
meningeal infection along the perivascular spaces. Sometimes,
the mucinous pseudocysts are small, but larger cysts can also
been seen in basal ganglia, cerebellum due to the confusion of
smaller lesions. Third, parenchymal involvement from cryp-
tococcus also have minimal inflammatory reaction and large
amount of fungal organisms accumulated in the cortex or
subcortical white matter through perivascular spaces con-
nected to subarachnoid spaces or parenchyma micro vessels.
All of these process result from the immunodeficiency of
phagocytic cell function in the VRS which leads to paren-
chymal invasion and proliferation.
4. Imaging characterization of cryptococcal
meningoencephalitis
Not all of the cryptococcal meningoencephalitis had posi-
tive imaging findings. Normal brain imaging (47% by CT and
8% by MR) did not exclude cryptococcal meningoencepha-
litis. Approximately 21%e27% cases had typical cryptococcal
meningoencephalitis on MRI [20]. The typical imaging ap-
pearances of cryptococcal meningoencephalitis include:
dilated VRS, pseudocysts, cryptococcoma, leptomeningeal or
parenchymal enhancing lesions and hazy brain base [21e24].
Pseudocysts were named as lesions of round or oval hyper-
intensity on T2WI and hypo-intensity on both T1WI and
FLAIR without restricted diffusion on DWI (iso- or hypo-
intensity on DWI and slightly hyper-intensity on ADC)
[20,25]. Pseudocysts can coexist with the dilated perivascular
spaces (Fig. 1). As infection disseminates along the VRS that
adjacent to perforating arteries, perivascular spaces may
become large with this mucoid organism. Punctate hyper-
intensities on T2WI representing pseudocysts and dilated
perivascular spaces are generally seen in basal ganglia, thal-
amus, midbrain and cerebellum. These appearances werePlease cite this article in press as: Xia S, et al., Imaging characterization of crypto
dx.doi.org/10.1016/j.jrid.2016.05.003characteristic for cryptococcal infection of CNS which
generally incites no or mild edema or enhancement.
Cryptococcoma can be defined as lesions in which the
cryptococcal organisms have involved parenchyma with
granuloma consisting of lymphocytes, macrophages, and
foreign body giant cells [18]. Cryptococcoma is more likely to
be seen in immunocompetent patients [26]. Delayed imaging
and double dose of contrast materials will better show
meningeal and cryptococcoma enhancement [21,27].
Meningitis or meningoencephalitis was defined as lep-
tomeningeal or dural thickening combined with focal paren-
chymal edema (Fig. 2) [20]. FLAIR and contrast enhanced
MRI are the most sensitive sequences to show the meningitis
or meningoencephalitis. Not all of the meningitis or menin-
goencephalitis had obvious contrast enhancement and the
reason maybe relate with the stage of inflammation and body
immunity. In the early stage with only edema, no or slight
inflammatory reaction was found and with antimycotic ther-
apy, the recovered immunity of the body can have good in-
flammatory response to form the cryptococcoma and then
circular or linear contrast enhancement [16,17].
‘Hazy brain base’ sign can also been detected on MRI
which was defined as an uniform and symmetrical hazy T2
signal increase on the basal brain such as basal ganglia,
midbrain, thalamus and hypothalamus (Fig. 3). These areas are
belonging to the anterior and posterior perforate substances
where the perforating arteries enter the brain. The lesions
show symmetrical hyperintensity on both T2WI and FLAIR.
Hazy brain base was supposed to represents brain edema duecoccal meningoencephalitis, Radiology of Infectious Diseases (2016), http://
Fig. 2. Meningitis. Left parietal cortex was shown with swelling on T2WI and the adjacent sulcus was shown to be narrowed (A). Linear contrast enhancement of
left parietal lobe was also demonstrated (B).
Fig. 3. Hazy brain sign. Hazy brain base was found symmetrical hyperintensity
on T2WI involving parenchyma of basal brain.
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with perivascular spaces [20].
In the pre-era of using HAART, the inflammatory response
around cryptococcomas is mild or absent due to the status of
immunodeficiency of the patients [20]. With antimycotic
treatment and recovery of the immunity, the body can
have ability to confine the infection to form abscesses or
granulomas. Some papers reported that all patients under
immune reconstitution had leptomeningeal enhancement and
some combined with parenchymal involvement [20,28]. AndPlease cite this article in press as: Xia S, et al., Imaging characterization of crypto
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blood cell count (WBC). Other papers reports that cerebral
atrophy had been less seen because of the decreased incidence
of HIV-associated dementia after using HAART [41]. The
treatment of HAART may had great effect on the imaging
appearances of cryptococcal meningoencephalitis due to its
verified effect on the local production of IL-8 and fungal
virulence [9,10,42]. But some other papers did not find the
effect of HAART on the imaging appearances. This needs
further large cohort study to confirm and compare the prog-
nosis with the different imaging characterization.
Cryptococcal infection can also occur in the HIV-negative
patients and the predisposing factors are diabetes [29e32].
The basic imaging of cryptococcal infection in HIV-negative is
similar to that of HIV-positive [33]. They are more likely to
present with cryptococcomas, and contrast enhancement of
cryptococcomas and meninges might occur more often as a
result of an immunologic reaction by the host [34]. The main
findings are meningoencephalitis and polycranial neuritis [32].
The main difference is that most HIV-negative patients with
CNS cryptococcal infection will recover totally with appro-
priate therapy but HIV-positive patients will persist or aggra-
vate pending on the immunity of the patients [32,33].
Imaging plays an important role in the evaluation of cryp-
tococcal infection of the brain. Some literature reported
abnormal findings correlated with higher risk of death [35,36].
MRS is new technique that can also been applied in the evalu-
ation of cryptococcal infection. Increased lactate and decreased
NAA, choline and creatine suggested neuronal injury and
Gliosis [37e39]. Some paper reported that high concentration of
alpha-trehalose is specific for diagnostic of C. neoformans [40].
5. Complications of cryptococcal meningoencephalitis
Cerebral ischemic vascular disease can also combined with
cryptococcal meningoencephalitis. Acute lacunar infarcts
manifested hyperintensity on DWI and hypointensity on ADCcoccal meningoencephalitis, Radiology of Infectious Diseases (2016), http://
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brain area supplied by perforating artery. Acute infarction are
often accompanied by ‘hazy brain base’ which indicate that
the infarctions might come from vasculitis of perforating ar-
teries due to extension of the fungal invasion along peri-
vascular spaces at brain base. 4% of patients with cryptococcal
meningoencephalitis can have cerebral infarctions the acute
stage or during the treatment [18].
Intracranial hypertension (ICH) is one of the most severe
neurological complications and morbidity and mortality are
high [41,42]. Approximately 50% of patients with crypto-
coccal meningoencephalitis had ICH and with intracranial
pressure over than 200 mm H2O [42]. The mechanism for the
ICH maybe related with the occlusion of CSF outflow from a
great burden of yeasts and polysaccharide staying the arach-
noid villi. Lumber puncture or inadequate CSF drainage
maybe risks for the development of brain stem herniation [43].
CT or MRI revealed normal or decreased size of ventricles.
MRI sagittal imaging can clearly detect the brain stem
herniation.
Hydrocephalus is the most common complication. The
reason for the obstructive hydrocephalus may be related with
cryptococcomas within the choroid plexus or subependymal
area [22,33,44].
Calcification was rare but can be detected and this can be
regarded as a sequela from chronic infection [17,23].
6. Interaction between Immune reconstitution syndrome
and cryptococcal meningoencephalitis after HAART
Immune reconstitution syndrome (IRS) was defined as
emergence of a past quiescent or incubating infection after
HAART therapy [45e47]. IRS is a serious complication
associated with cryptococcal meningoencephalitis. It can
occur within 1e4 weeks or 2e4 months after institution of
HAART [20]. One paper reported that a case with recurrent
cryptococcal meningoencephalitis combined with IRS eight
years after the initial diagnosis of cryptococcal meningoen-
cephalitis [35,46]. 10%e42% of CM patients will develop IRS
and 66% of them will die from it. In China the occurrence of
IRS is about 17.5% in CM patients. The pathogenesis of these
entities is still controversial. The definitive diagnostic criteria
and therapeutic guidelines for IRS still need further investi-
gation. Combination of antifungal and corticosteroid therapy
may be effective and worthwhile [12,13].
7. Differentiation of cryptococcal meningoencephalitis
from other entities
Lots of mimics can combine with the cryptococcal
meningoencephalitis, especially in the patients with AIDS.
The enhanced lesions in the basal ganglia should considered
toxoplasmosis or primary lymphoma. Subependymal contrast
lesions may be primary lymphoma or cytomegalovirus
encephalitis.
In a word, there are some of the important imaging findings
of the cryptococcal meningoencephalitis, including: dilatedPlease cite this article in press as: Xia S, et al., Imaging characterization of crypto
dx.doi.org/10.1016/j.jrid.2016.05.003VRS, pseudocysts, cryptococcoma, leptomeningeal or paren-
chymal enhancing lesions and hazy brain base. Therapy of
HAART can help patients gain immunity and it has a great
effect on the imaging appearances of cryptococcal meningo-
encephalitis with more contrast enhancement. IRS could also
coexist with the cryptococcal meningoencephalitis and com-
bined treatment of antifungal and corticosteroid therapy may
be effective and worthwhile.
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